Price $1.02 |
Market Cap
24.3M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
0.85
|
P/S
3.45
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-22K
|
FCF
-6.4
|
|
Op. Margin
-686.60%
|
Net Margin
-717.10%
|
ROE
-348.70%
|
ROI
-527.40%
|
|
ROA
-186.00%
|
EPS Growth
65.20%
|
Current Ratio
1.3
|
Debt/Equity
33.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Harvard Bioscience, Inc. (HBIO) | $2.10 | - | - | 87.4M | Strong Buy |
| ImmuCell Corporation (ICCC) | $6.70 | - | - | 44.5M | Strong Buy |
| Streamline Health Solutions In (STRM) | $1.80 | - | - | 26.4M | Strong Buy |
| Bausch Health Companies Inc (BHC) | $22.00 | - | - | 7.55B | Strong Buy |
| Milestone Scientific Inc. (MLSS) | $0.33 | - | - | 13.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
